{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"}],"units":"Participants"}],"description":"Incidence of acute GVHD grades II-IV (before and after T cell add back) Modified Glucksberg grading","groups":[{"description":"Bone marrow stem cell transplant program to improve the outcome of allogeneic Bone Marrow Transplant for hematologic malignancies. Immunosuppression including cyclosporine will be given six days prior to transplant up to 21 days post transplant. CD34 selection and T cell depletion using Isolex 300i immuno-magnetic cell selection and immunosuppression during peri- transplant.","id":"OG000","title":"Bone Marrow Transplantation Using Nexell Isolex 300i"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"First 100 days","title":"Acute GVHD Overall","type":"SECONDARY","unitOfMeasure":"participants"}